Concepedia
Statistics
Publications
40
Citations
5.2K
H-Index
25
Active since
2000
Affiliations
University of Colorado Denver(Current)
The University of Texas MD Anderson Cancer Center
City Of Hope National Medical Center
Memorial Sloan Kettering Cancer Center
The Wistar Institute
Enkhtsetseg Purev is an author at University of Colorado Denver specializing in medicine, oncology, and hematologic oncology.
Publications per year
2000–2025
Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
M. Lia Palomba, Leo I. Gordon, Matthew A. Lunning et al. · The Lancet · 2020 · 2.3K citations
Medicine, Oncology, Pharmacology +13
Venetoclax with azacitidine disrupts energy metabolism and targets leukemia stem cells in patients with acute myeloid leukemia
Daniel A. Pollyea, Brett M. Stevens, Courtney L. Jones et al. · Nature Medicine · 2018 · 797 citations · Full text
Medicine, Oncology, Pharmacology +12
Chronic Myeloid Leukemia, Version 1.2019, NCCN Clinical Practice Guidelines in Oncology
Jerald P. Radich, Michael W. Deininger, Camille N. Abboud et al. · Journal of the National Comprehensive Cancer Network · 2018 · 282 citations · Full text
Medicine, Hematology, Oncology +15
Two-year follow-up of lisocabtagene maraleucel in relapsed or refractory large B-cell lymphoma in TRANSCEND NHL 001
Jeremy S. Abramson, M. Lia Palomba, Leo I. Gordon et al. · Blood · 2023 · 171 citations · Full text
Medicine, Oncology, Hematologic Oncology +11
Updated safety and long term clinical outcomes in TRANSCEND NHL 001, pivotal trial of lisocabtagene maraleucel (JCAR017) in R/R aggressive NHL.
Jeremy S. Abramson, Leo I. Gordon, Maria Lia Palomba et al. · Journal of Clinical Oncology · 2018 · 168 citations
Medicine, Pharmacology, Cell Therapy +12
1–5 of 40